Core Viewpoint - UnitedHealth Group Inc has shown signs of stabilization after a challenging year, with recent earnings suggesting a potential recovery for the company and its investors [1][3]. Financial Performance - UnitedHealth reported third-quarter EPS of $2.92, exceeding Wall Street's estimate of $2.79, with revenue of $113.16 billion, slightly below consensus [2]. - The company raised its FY2025 outlook to at least $14.90 from a previous estimate of $14.65, indicating expectations for sustainable double-digit growth starting in 2027 [2]. Market Sentiment - The stock has experienced a 35% decline over the past year, but recent performance has led to a 6% increase in shares over the past month, with a 5% rally in pre-market trading following the earnings report [1][5]. - Hedge fund managers David Tepper and Michael Burry have maintained their positions, suggesting confidence in the company's recovery trajectory [4][5]. Recovery Outlook - Despite being down approximately 27% year-to-date, the upgrade in outlook and discussions of a growth rebound in 2027 provide a more optimistic narrative for UnitedHealth's recovery [6]. - The recent earnings report is viewed as a positive signal that the company's turnaround strategy may be effective [6].
UnitedHealth Delivers The Quarter Tepper, Burry Have Been Waiting For